FBTTX Mutual Fund (Fidelity Advisor Biotechnology Fund Class M) is managed by Fidelity Investments (US) with $135.9M in net assets. FBTTX expense ratio is 1.21%, holding 84 positions across sectors including Health Care, Financials, Unknown. Inception date: 2000-12-27.

FBTTX performance shows a YTD return of 4.33%. The 1-year return is 43.35% and the 5-year return is 7.78%. FBTTX dividend yield stands at 1.20%, paid semi-annually.

FBTTX top holdings include Abbvie Inc (16.6%), Alnylam Pharmace (7.7%), Gilead Sciences Inc (5.5%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.7%), Fidelity Securities Lending Cash Central Fund (4.3%). View all FBTTX holdings, sector breakdown, or dividend history.

FBTTX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTTX alternatives are available via the screener, along with tax-loss harvesting opportunities.